TotalMarketCap

Annovis Bio

ANVSNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$28.076 M

$0.65 -46.07%

Close of 6 Nov 2026

As of 6 Nov 2026, Annovis Bio (ANVS) has a market capitalization of $28.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$28.9M

Loss-making

Shares outstanding

42,606,152

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #365BriaCell TherapeuticsBCTX$28.7M
  2. #366Incannex HealthcareIXHL$28.6M
  3. #367Annovis BioANVS$28.1M
  4. #368Adicet BioACET$27.6M
  5. #369BeyondSpringBYSI$26.6M

What if Annovis Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$656,327.74

Per share 1,005,712× higher

Bitcoin $1.53T

$35,512.75

Per share 54,417× higher

Apple $5.02T

$116,585.05

Per share 178,647× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Annovis Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.